Biomarker-guided classification scheme of neurodegenerative diseases

被引：18

作者：

Baldacci, Filippo ^{[1
,2
,3
]}

Lista, Simone ^{[4
,5
,6
]}

Garaci, Francesco ^{[7
,8
]}

Bonuccelli, Ubaldo ^{[1
]}

Toschi, Nicola ^{[7
,9
,10
]}

Hampel, Harald ^{[2
,3
,4
,5
]}

机构：

[1] Univ Pisa, Dept Clin & Expt Med, I-56126 Pisa, Italy

[2] Hop La Pitie Salpetriere, Inst Memory & Alzheimers Dis IM2A, Brain & Spine Inst ICM, UMR S 1127,Dept Neurol, F-75651 Paris, France

[3] Pierre & Marie Curie Univ, Sorbonne Univ, Paris VI, F-75005 Paris, France

[4] AXA Res Fund, F-75005 Paris, France

[5] Pierre & Marie Curie Univ Chair, F-75005 Paris, France

[6] Hop La Pitie Salpetriere, IHU A ICM Paris Inst Translat Neurosci, F-75651 Paris, France

[7] Univ Roma Tor Vergata, Dept Biomed & Prevent, Fac Med, I-00173 Rome, Italy

[8] San Raffaele Cassino Nursing Home, I-03043 Cassino, FR, Italy

[9] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA

[10] Harvard Med Sch, Charlestown, MA 02129 USA

来源：

JOURNAL OF SPORT AND HEALTH SCIENCE | 2016年 / 5卷 / 04期

关键词：

ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DEMENTIA;

D O I：

10.1016/j.jshs.2016.08.007

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：383 / 387

页数：5

共 50 条

[21] Biomarker-guided therapy for colorectal cancer: strength in complexity
Anita Sveen
Scott Kopetz
Ragnhild A. Lothe
Nature Reviews Clinical Oncology, 2020, 17 : 11 - 32
[22] Reducing the risk of failure: biomarker-guided trial design
Townsend, Michael J.
Arron, Joseph R.
NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (08) : 517 - 518
[23] Evaluating statistical characteristics of biomarker-guided trial designs
Antoniou, Miranta
Jorgensen, Andrea
Kolamunnage-Dona, Ruwanthi
TRIALS, 2015, 16
[24] Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis
Deniau, Benjamin
Takagi, Koji
Asakage, Ayu
Mebazaa, Alexandre
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (02) : 95 - 102
[25] Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
Yang, Haitang
Xu, Duo
Schmid, Ralph A.
Peng, Ren-Wang
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[26] Biomarker-guided antibiotic therapy-strengths and limitations
Nora, David
Salluh, Jorge
Martin-Loeches, Ignacio
Povoa, Pedro
ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (10)
[27] Biomarker-guided stratification of autoimmune patients for biologic therapy
Ivison, Sabine
Des Rosiers, Christine
Lesage, Sylvie
Rioux, John D.
Levings, Megan K.
CURRENT OPINION IN IMMUNOLOGY, 2017, 49 : 56 - 63
[28] Biomarker investigations in neurodegenerative diseases
Urbani, A.
Del Boccio, P.
Bernardini, S.
Di Ilio, C.
Gambi, D.
Stefani, A.
Federici, G.
MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S166 - S166
[29] Neurodegenerative Diseases Pattern as a Biomarker?
不详
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2014, 82 (11) : 612 - 612
[30] Homocysteine: a biomarker in neurodegenerative diseases
Herrmann, Wolfgang
Obeid, Rima
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (03) : 435 - 441

← 1 2 3 4 5 →